112.41
+1.595(+1.44%)
Currency In USD
| Previous Close | 110.82 |
| Open | 110 |
| Day High | 113.99 |
| Day Low | 109.03 |
| 52-Week High | 124.73 |
| 52-Week Low | 49 |
| Volume | 45,218 |
| Average Volume | 66,548 |
| Market Cap | 3.92B |
| PE | -58.55 |
| EPS | -1.92 |
| Moving Average 50 Days | 84.74 |
| Moving Average 200 Days | 67.72 |
| Change | 1.6 |
If you invested $1000 in Belite Bio, Inc (BLTE) since IPO date, it would be worth $10,614.73 as of November 14, 2025 at a share price of $112.41. Whereas If you bought $1000 worth of Belite Bio, Inc (BLTE) shares 2 years ago, it would be worth $2,967.53 as of November 14, 2025 at a share price of $112.41.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Belite Bio to Host Webcast on November 10, 2025, to Discuss Third Quarter 2025 Financial Results
GlobeNewswire Inc.
Nov 03, 2025 1:00 PM GMT
SAN DIEGO, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Belite Bio, Inc (NASDAQ: BLTE), a clinical-stage drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical needs, today
Belite Bio Announces UK’s Medicines and Healthcare Products Regulatory Agency Agrees to Conditional Marketing Authorization Application Based on Interim Analysis Results for the Treatment of Stargardt Disease with Tinlarebant
GlobeNewswire Inc.
Nov 02, 2025 2:00 PM GMT
MHRA response is based on the Phase 3 DRAGON interim analysis results Topline final data expected in Q4 2025 SAN DIEGO, Nov. 02, 2025 (GLOBE NEWSWIRE) -- Belite Bio, Inc. (NASDAQ: BLTE), a clinical-stage drug development company focused on advancin
Belite Bio to Participate in the Deutsche Bank ADR Virtual Investor Conference
GlobeNewswire Inc.
Oct 29, 2025 12:00 PM GMT
SAN DIEGO, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Belite Bio Inc (NASDAQ: BLTE) (“Belite” or the “Company”), a clinical-stage drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant